Gloria Kayani

2.7k citations

45 papers · 1.5k indexed · h-index 22

Cardiology and Cardiovascular Medicine top 1%
Internal Medicine top 0.5%
Epidemiology
Surgery
Economics and Econometrics top 10%

Co-authors: Ajay K. Kakkar Sylvia Haas Shinya Goto Samuel Z. Goldhaber LG Mantovani Jean‐Pierre Bassand David Fitzmaurice Frank Misselwitz
Topics: Atrial Fibrillation Management and Outcomes (38 papers)Venous Thromboembolism Diagnosis and Management (29 papers)Cardiac Arrhythmias and Treatments (21 papers)
Cited by: Internal Medicine Cardiology and Cardiovascular Medicine Emergency Medical Services
Journals: CirculationSHILAP Revista de lepidopterologíaJournal of the American College of Cardiology
Partner nations: United Kingdom United States Canada

In The Last Decade

Gloria Kayani

42 papers receiving 1.4k citations

Peers

Countries citing papers authored by Gloria Kayani

Since Specialization

Citations

This map shows the geographic impact of Gloria Kayani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gloria Kayani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gloria Kayani more than expected).

Fields of papers citing papers by Gloria Kayani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gloria Kayani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gloria Kayani. The network helps show where Gloria Kayani may publish in the future.

Co-authorship network of co-authors of Gloria Kayani

This figure shows the co-authorship network connecting the top 25 collaborators of Gloria Kayani. A scholar is included among the top collaborators of Gloria Kayani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gloria Kayani. Gloria Kayani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD‐AF registry 2023 ·Diabetes Obesity and Metabolism ·Jean‐Pierre Bassand,Saverio Virdone,A. John Camm,Keith A.A. Fox,Samuel Z. Goldhaber,Shinya Goto,Sylvia Haas,Werner Hacke,Gloria Kayani,Mátyás Keltai,Frank Misselwitz,Karen S. Pieper,Alexander G.G. Turpie,Freek W.A. Verheugt,Ajay K. Kakkar,(unknown)	1
2	Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry 2023 ·The American Journal of Medicine ·Samuel Z. Goldhaber,Jean‐Pierre Bassand,A. John Camm,Saverio Virdone,Karen S. Pieper,Frank Cools,Ramón Corbalán,Bernard J. Gersh,Shinya Goto,Sylvia Haas,Frank Misselwitz,Alexander Parkhomenko,Jan Steffel,Janina Stępińska,Alexander G.G. Turpie,Freek W.A. Verheugt,Gloria Kayani,Ajay K. Kakkar	2
3	Outcomes of Oral Anticoagulation in Atrial Fibrillation Patients With or Without Comorbid Vascular Disease: Insights From the GARFIELD-AF Registry 2023 ·The American Journal of Medicine ·Freek W.A. Verheugt,Keith A.A. Fox,Saverio Virdone,Giuseppe Ambrosio,Bernard J. Gersh,Sylvia Haas,Karen S. Pieper,Gloria Kayani,A. John Camm,Alexander Parkhomenko,Frank Misselwitz,Hany Ragy,Hugo Ten Cate,Mátyás Keltai,Ajay K. Kakkar	3
4	Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry 2023 ·Open Heart ·(unknown),Saverio Virdone,A. John Camm,Keith A.A. Fox,Jean‐Pierre Bassand,Alexander G.G. Turpie,Seil Oh,Marianne Brodmann,Frank Cools,Antônio Carlos Pereira Barretto,Jørn Dalsgaard Nielsen,Sylvia Haas,Gloria Kayani,Karen S. Pieper,Ajay K. Kakkar	3
5	Two-year outcomes of UK patients newly diagnosed with atrial fibrillation: findings from the prospective observational cohort study GARFIELD-AF 2022 ·British Journal of General Practice ·(unknown),Saverio Virdone,Richard Hobbs,A. John Camm,Keith A.A. Fox,Karen S. Pieper,Gloria Kayani,David Fitzmaurice	3
6	Clinical Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation Presentations in GARFIELD-AF: Implications for AF Screening 2021 ·The American Journal of Medicine ·Harry Gibbs,Ben Freedman,Mårten Rosenqvist,Saverio Virdone,Wael Al Mahmeed,Giuseppe Ambrosio,A. John Camm,Barry Jacobson,Carlos Jerjes‐Sánchez,Gloria Kayani,Ali̇ Oto,Е. П. Панченко,Hany Ragy,Ajay K. Kakkar	34
7	Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE 2021 ·Research and Practice in Thrombosis and Haemostasis ·Walter Ageno,Alfredo E. Farjat,Sylvia Haas,Jeffrey I. Weitz,Samuel Z. Goldhaber,Alexander G.G. Turpie,Shinya Goto,Pantep Angchaisuksiri,Joern Dalsgaard Nielsen,Gloria Kayani,Sebastian Schellong,Henri Bounameaux,LG Mantovani,Paolo Prandoni,Ajay K. Kakkar	23
8	Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry 2021 ·Journal of Thrombosis and Haemostasis ·Frank Cools,(unknown),Alan John Camm,Jean‐Pierre Bassand,Freek W.A. Verheugt,Shu Yang,Anastasios A. Tsiatis,David Fitzmaurice,Samuel Z. Goldhaber,Gloria Kayani,Shinya Goto,Sylvia Haas,Frank Misselwitz,Alexander G.G. Turpie,Keith A.A. Fox,Karen S. Pieper,Ajay K. Kakkar	24
9	Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD‐VTE 2021 ·Journal of Thrombosis and Haemostasis ·Omri Cohen,Walter Ageno,Alfredo E. Farjat,Alexander G.G. Turpie,Jeffrey I. Weitz,Sylvia Haas,Shinya Goto,Samuel Z. Goldhaber,Pantep Angchaisuksiri,Harry Gibbs,Peter MacCallum,Gloria Kayani,Sebastian Schellong,Henri Bounameaux,LG Mantovani,Paolo Prandoni,Ajay K. Kakkar	10
10	Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE 2021 ·Thrombosis Research ·Pantep Angchaisuksiri,Shinya Goto,Alfredo E. Farjat,(unknown),Soo‐Mee Bang,Chern-En Chiang,Zhi‐Cheng Jing,Katsuhiro Kondo,Jameela Sathar,Eric Tse,(unknown),Gloria Kayani,Jeffrey I. Weitz,Walter Ageno,Samuel Z. Goldhaber,Ajay K. Kakkar	14
11	The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE 2021 ·Thrombosis Research ·Shinya Goto,Alexander G.G. Turpie,Alfredo E. Farjat,Jeffrey I. Weitz,Sylvia Haas,Walter Ageno,Samuel Z. Goldhaber,Pantep Angchaisuksiri,Gloria Kayani,Peter MacCallum,Sebastian Schellong,Henri Bounameaux,LG Mantovani,Paolo Prandoni,Ajay K. Kakkar	9
12	Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE 2020 ·Thrombosis Research ·Henri Bounameaux,Sylvia Haas,Alfredo E. Farjat,Walter Ageno,Jeffrey I. Weitz,Samuel Z. Goldhaber,Alexander G.G. Turpie,Shinya Goto,Pantep Angchaisuksiri,Joern Dalsgaard Nielsen,Gloria Kayani,Sebastian Schellong,LG Mantovani,Paolo Prandoni,Ajay K. Kakkar	18
13	Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF 2019 ·The American Journal of Medicine ·Freek W.A. Verheugt,Giuseppe Ambrosio,Dan Atar,Jean‐Pierre Bassand,A. John Camm,Juan Pablo Costabel,David Fitzmaurice,(unknown),Samuel Z. Goldhaber,Shinya Goto,Sylvia Haas,Petr Janský,Gloria Kayani,Janina Stępińska,Alexander G.G. Turpie,Martin van Eickels,Ajay K. Kakkar	9
14	Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation 2018 ·PLoS ONE ·Jean‐Pierre Bassand,Gabriele Accetta,Wael Al Mahmeed,Ramón Corbalán,John W. Eikelboom,David Fitzmaurice,Keith A.A. Fox,Haiyan Gao,Samuel Z. Goldhaber,Shinya Goto,Sylvia Haas,Gloria Kayani,Karen S. Pieper,Alexander G.G. Turpie,Martin van Eickels,Freek W.A. Verheugt,Ajay K. Kakkar,(unknown)	77
15	Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation 2017 ·BMJ Open ·Keith A.A. Fox,Joseph E. Lucas,Karen S. Pieper,Jean‐Pierre Bassand,A. John Camm,David Fitzmaurice,Samuel Z. Goldhaber,Shinya Goto,Sylvia Haas,Werner Hacke,Gloria Kayani,Ali̇ Oto,LG Mantovani,Frank Misselwitz,Jonathan P. Piccini,Alexander G.G. Turpie,Freek W.A. Verheugt,Ajay K. Kakkar	88
16	Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry 2017 ·BMJ Open ·A. John Camm,Gabriele Accetta,Wael Al Mahmeed,Giuseppe Ambrosio,Samuel Z. Goldhaber,Sylvia Haas,Petr Janský,Gloria Kayani,Frank Misselwitz,Seil Oh,Ali̇ Oto,Pekka Raatikainen,Jan Steffel,Martin van Eickels,Ajay K. Kakkar	31
17	Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry 2017 ·European Heart Journal ·Freek W.A. Verheugt,Haiyan Gao,Wael Al Mahmeed,Giuseppe Ambrosio,Pantep Angchaisuksiri,Dan Atar,Jean‐Pierre Bassand,A. John Camm,Frank Cools,John W. Eikelboom,Gloria Kayani,Toon Wei Lim,Frank Misselwitz,Karen S. Pieper,Martin van Eickels,Ajay K. Kakkar,(unknown)	28
18	Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF 2016 ·European Heart Journal ·Jean‐Pierre Bassand,Gabriele Accetta,Alan John Camm,Frank Cools,David Fitzmaurice,Keith A.A. Fox,Samuel Z. Goldhaber,Shinya Goto,Sylvia Haas,Werner Hacke,Gloria Kayani,LG Mantovani,Frank Misselwitz,Hugo Ten Cate,Alexander G.G. Turpie,Freek W.A. Verheugt,Ajay K. Kakkar	196
19	Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry 2016 ·International Journal of Cardiology ·Seil Oh,Shinya Goto,Gabriele Accetta,Pantep Angchaisuksiri,A. John Camm,Frank Cools,Sylvia Haas,Gloria Kayani,Yukihiro Koretsune,Toon Wei Lim,Frank Misselwitz,Martin van Eickels,Ajay K. Kakkar	63
20	Evolving quality standards for large-scale registries: the GARFIELD-AF experience 2016 ·European Heart Journal - Quality of Care and Clinical Outcomes ·Keith A.A. Fox,Bernard J. Gersh,S Traoré,A. John Camm,Gloria Kayani,Anders Krogh,(unknown),Ajay K. Kakkar,(unknown)	28

About Gloria Kayani

Gloria Kayani is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Family Practice, having authored 45 papers that have together received 1.5k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (38 papers), Venous Thromboembolism Diagnosis and Management (29 papers) and Cardiac Arrhythmias and Treatments (21 papers). The work is most often cited by research in Internal Medicine (636 citations), Cardiology and Cardiovascular Medicine (1.3k citations) and Emergency Medical Services (67 citations). Gloria Kayani has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Ajay K. Kakkar, Sylvia Haas, Shinya Goto, Samuel Z. Goldhaber, LG Mantovani, Jean‐Pierre Bassand, David Fitzmaurice, Frank Misselwitz, Alexander G.G. Turpie and A. John Camm. Their work appears in journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact